Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-07-02

FDA Approved: EMTRICITABINE — Original Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved Cipla USA Inc.'s original application for generic emtricitabine, enabling its use in HIV-1 treatment regimens.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Emtricitabine (Emtricitabine)

Snippet

ORIG AP for EMTRICITABINE (EMTRICITABINE)